reference/4492982

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4492982

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	1362
issn	0315-162X 1499-2752
issueIdentifier	7
pageRange	1355-1362
publicationName	The Journal of Rheumatology
startingPage	1355
bibliographicCitation	Gladman DD, Bombardier C, Thorne C, Haraoui B, Khraishi M, Rahman P, Bensen W, Syrotuik J, Poulin-Costello M. Effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting: the REPArE trial. J Rheumatol. 2011 Jul;38(7):1355–62. doi: 10.3899/jrheum.100698. PMID: 21572156.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5083-2137 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8713cf15708999ac7431452773909075 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2981ada73bcaeb51a6e4766d64c0852e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cb26708c1d4c5a5f44ea8d896890f7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e7c9e98ea2129349e1b75cee9b64641 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad3a7c135eee763ca77e617e3d2024b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52661de86cbbcb1414897e897a83a076 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c47188841dc741465b0fe9ca363b107 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43b84e2cc9c823b98a2ab7f3854f83ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_850528041438a8d1109be6fdfcb60056
date	2011-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21572156 https://doi.org/10.3899/jrheum.100698
isPartOf	https://portal.issn.org/resource/ISSN/0315-162X https://portal.issn.org/resource/ISSN/1499-2752 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5243
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Effectiveness and Safety of Etanercept in Patients with Psoriatic Arthritis in a Canadian Clinical Practice Setting: The REPArE Trial
discusses	http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0376295 http://id.nlm.nih.gov/mesh/M0022150 http://id.nlm.nih.gov/mesh/M0027329 http://id.nlm.nih.gov/mesh/M0276736
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018501Q000009 http://id.nlm.nih.gov/mesh/D015535Q000188 http://id.nlm.nih.gov/mesh/D014409Q000037 http://id.nlm.nih.gov/mesh/D018124Q000627 http://id.nlm.nih.gov/mesh/D007074Q000627 http://id.nlm.nih.gov/mesh/D007074Q000009 http://id.nlm.nih.gov/mesh/D018501Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D002170 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D015994 http://id.nlm.nih.gov/mesh/D007407 http://id.nlm.nih.gov/mesh/D005221Q000503 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D005221Q000453 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004185 http://id.nlm.nih.gov/mesh/D008137 http://id.nlm.nih.gov/mesh/D004526Q000502 http://id.nlm.nih.gov/mesh/D006304 http://id.nlm.nih.gov/mesh/D000068800 http://id.nlm.nih.gov/mesh/D015535Q000503
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8214 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9751 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9238 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9007

Total number of triples: 65.